ClinicalTrials.gov
public full text
Public Domain
The p53 Colorectal Cancer Trial
Single center, open labeled, phase 2 clinical trial, where patients with metastatic colorectal cancer are selected for treatment with dose dense Cyclophosphamide every second week based on TP53 mutation status; i.e. only patients with TP53 mutated tumors may be included in the treatment arm.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer#857739
- Treatment Strategies for Primarily Generalized Colorectal Cancer#839857
- Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer#1173382
- Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer#889556
- Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases#882906
Record · ID 852652
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive